Уноси

• Generic pregabalin; current situation and implications for health authorities, generics and biosimilars manufacturers in the future (2015-05)

  B. Godman, M. Wilcock, A. Martin, S. Bryson, C. Baumgartel, T. Bochenek, W. de Bruyn, L. Sović-Brkičić, M. D'Agata, A. Fogele, A. Coma Fuste, J. Fraeyman, J. Furst, K. Garuoliene, H. Herholz, M. Hoffman, S. Jayathissa, H. Kwon, I. Langner, M. Kalaba, E. Magnusson, E. Anderse Karlssen, O. Laius, V. Marković Peković, E. Magnusson, S. McTaggart, H. Pedersen, J. Piessnegger, A. Ringerud, G. Selke, C. Sermet, K. Schiffers, P. Skiold, D. Tomek, A. Viksna, A. Vitry, C. Zara, R. Malmstrom, Generic pregabalin; current situation and implications for health authorities, generics and biosimilars manufacturers in the future, Generics and Biosimilars Initiative Journal, Vol. 4, No. 3, pp. 125 - 135, May, 2015

• Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future (2016-07)

  W. de Bruyn, C. Ibanez, H. Pedersen, A. Akan, P. Vella Bonanno, L. Sović-Brkičić, A. Bucsics, G. Dedet, J. Eriksen, J. Fadare, J. Furst, G. Gallego, I. Godoi, A. Guerra Junior, H. Gursoz, S. Jan, J. Jones, R. Joppi, S. Kerman, O. Laius, N. Madzikwa, E. Magnusson, M. Maticic, V. Marković Peković, A. Massele, O. Ogunleye, A. O'Leary, J. Piessnegger, C. Sermet, S. Simoens, C. Tiroyakgosi, I. Truter, M. Thyberg, K. Tomek, M. Wladysiuk, S. Vandoros, E. Vural, C. Zara, Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future, Frontiers in Pharmacology, Vol. 7, pp. 1 - 18, Jul, 2016